Aptiom

Active Ingredient(s): Eslicarbazepine Acetate
FDA Approved: * November 8, 2013
Pharm Company: * SUNOVION PHARMS INC
Category: Anticonvulsant

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Aptiom Overview

Eslicarbazepine acetate (trade names Aptiom in North America, Zebinix in Europe, Exalief in Russia, Eslicarba in Egypt ), abbreviated as ESL, is an anticonvulsant medication approved for use in Europe and the United States as monotherapy or adjunctive therapy (additional therapy) for partial-onset seizures epilepsy.[2][3][4] Similarly to oxcarbazepine, ESL behaves as a prodrug to (S)-(+)-licarbazepine.[5] As such, their mechanis...

Read more Aptiom Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Eslicarbazepine_acetate

Recent Aptiom Forums: RSS Feed

Aptiom questions

I am on Aptiom for Trigeminal Neuralgia. Any info about side effects when Aptiom is increased. Now at 1200 mg. any info would be greatly appreciated. I think this is my last hope before going to narcotics which really doesn't work on this excruciating nerve pain. Already had two unsuccessful surgeries and was told no more. Thank you.Updaa ## Hello, Mary! How are you? I'm sorry that you're in so much pain. The side effects won't be different, when the dosage is raised, but you may experience them, again and they may be more intense than at lower dosages. The FDA lists the typical side effects of Aptiom as possibly including nausea, dizziness, tremor, double vision, headache and drowsiness. Is there anything else I can help with? ## Thank you very much for your help. ## My...

Updated
Aptiom reviews

Is anyone familiar with the epilepsy medication aptiom and what are the reviews? ## Hi Nicole, From the looks of it, you seem to be the first person to post about this specific medication here on MedsChat. But in terms of reviews, the FDA approved Aptiom back in 2013 based on three large clinical trials, including over 1,400 people who've been living with partial-onset seizures. According to these studies, Aptiom reportedly demonstrated a statistically significant reduction (of up to 50% or more) in standardized seizure frequency from where patients were prior to treatment. This is compared to a 22% reduction in patients who received a placebo. Based on this information alone, Aptiom sounds like a viable treatment option in my opinion. However, one must also consider pros and cons w...

Updated

Possible Dosages for this and Related Drugs:

Eslicarbazepine Acetate
  • Tablet: 200mg, 400mg, 600mg, 800mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Aptiom: (5 results)

Sorted by National Drug Code
  • 63402-202 Aptiom 200 mg/1 Oral Tablet by Sunovion Pharmaceuticals Inc.
  • 63402-204 Aptiom 400 mg/1 Oral Tablet by Sunovion Pharmaceuticals Inc.
  • 63402-206 Aptiom 600 mg/1 Oral Tablet by Sunovion Pharmaceuticals Inc.
  • 63402-208 Aptiom 800 mg/1 Oral Tablet by Sunovion Pharmaceuticals Inc.
  • 63402-248 Aptiom Oral Kit by Sunovion Pharmaceuticals Inc.

Other drugs which contain Eslicarbazepine Acetate or a similar ingredient: (1 result)

Related Aptiom Topics:

Aptiom questions
I am on Aptiom for Trigeminal Neuralgia. Any info about side effects when Aptiom is increased. Now at 1200 mg. any info ... 3 replies
Aptiom reviews
Is anyone familiar with the epilepsy medication aptiom and what are the reviews? ## Hi Nicole, From the looks of it, you... 2 replies






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA